细菌人工染色体
同源重组
生物
酵母人工染色体
人类人工染色体
可选择标记
遗传学
基因
多克隆站点
基因靶向
克隆(编程)
分子生物学
载体(分子生物学)
质粒
染色体
重组DNA
基因组
基因定位
计算机科学
程序设计语言
作者
Narayanan Kulathuramaiyer,Robert Williamson,Y. Zhang,Stewart Af,PA Ioannou
出处
期刊:Gene Therapy
[Springer Nature]
日期:1999-03-01
卷期号:6 (3): 442-447
被引量:138
标识
DOI:10.1038/sj.gt.3300901
摘要
Gene therapy studies require techniques that allow alteration of human genomic DNA sequences. Bacterial artificial chromosome cloning systems (BACs/PACs) bridge the gap between vectors with small inserts and yeast artificial chromosomes (YACs). We report the use of a second generation BAC vector, pEBAC, containing eukaryotic selectable markers and combining some of the best features of the BAC, PAC and HAEC systems, into which a 185 kb sequence containing the human beta-globin gene cluster was retrofitted. To permit the introduction of mutations corresponding to those causing human pathology, we have adapted an inducible homologous recombination system for use in E. coli DH10B cells, the host strain for BACs and PACs. Using this system, we have introduced PCR fragments carrying a selectable marker and a reporter gene downstream of the IVS-110 splicing mutation into a specific site within the beta-globin gene sequence. The use of this inducible system minimises the risk of unwanted rearrangements by recombination between repetitive elements and allows the introduction of relevant modifications or reporters at any specific sequence within BACs/PACs in E. coli DH10B cells.
科研通智能强力驱动
Strongly Powered by AbleSci AI